Brief: Diasorin Submits LIAISON NES Group A Strep Molecular Test To The U.S. FDA For 510(K) Clearance And CLIA Waiver

Diasorin

03/02/2026 11:23

Feb 3 (Reuters) - DiaSorin SpA DIAS.MI:

SUBMITS LIAISON NES GROUP A STREP MOLECULAR TEST TO THE U.S. FDA FOR 510(K) CLEARANCE AND CLIA WAIVER

Further company coverage: DIAS.MI

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))